| SOUTH ASIAN GUIDELINES FOR MANAGEMENT OF ENDOCRINE DISORDERS IN RAMADAN |
|
| Year : 2012 | Volume
: 16
| Issue : 4 | Page : 525-527 |
|
|
South Asian Consensus Guideline: Use of GLP-1 analogue therapy in diabetes during Ramadan
Md Faruque Pathan1, Rakesh Kumar Sahay2, Abdul Hamid Zargar3, Syed Abbas Raza4, AK Azad Khan1, Nazrul Islam Siddiqui5, Firoz Amin1, Sanjay Kalra6
1 Department of Endocrinology, BIRDEM, Dhaka, Bangladesh
2 Osmania Medical College, Hyderabad, India
3 Advanced Center for Diabetes and Endocrine Care, Srinagar, India
4 Shaukhat Khanum Cancer Hospital and Research Center, Lahore, Pakistan
5 Mymensingh Medical College, Mymensingh, Bangladesh
6 Department of Endocrinology, Bharti Hospital and BRIDE, Karnal, Haryana, India
Correspondence Address:
Md Faruque Pathan
Department of Endocrinology, BIRDEM, Dhaka
Bangladesh
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/2230-8210.98003
|
|
|
Ramadan is a lunar based month, during which Muslims across the world observe the ritual fast. This provides a challenge not only to the diabetic patient who wishes to observe the fast but also to the health care professional managing his diabetes. The challenge is to use therapies which are effective in maintaining good glycemic control and at the same time have a low propensity to cause hypoglycemia during the several hours of no calorie intake. The GLP-1 analogues are unique agents which are effective in providing glycemic reduction with a very low risk of hypoglycemia and hence find an important place in the management of diabetes during Ramadan. This Consensus Statement describes the pre-Ramadan assessment, planning, prescription and management and monitoring of patients who are on GLP-1 analogues, with or without other antidiabetic therapies. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
